Escherichia coli (ST866) in the Netherlands. A similar IncL/M plasmid was identified in both strains, suggesting within-patient horizontal transfer. Conclusion This case illustrates that OXA-48-carbapenemase-producing Enterobacteriaceae can be unnoticed without adequate laboratory detection procedures. Our observation stresses the importance of uniform and adequate laboratory methods for the timely and accurate detection of important antimicrobial resistance.
Gastroscopy showed an ulcer not related to non-Hodgkin lymphoma.
A few weeks later, her clinical situation worsened and a CT-scan showed an abscess in the right upper abdomen. Subsequently, drainage was performed. Culture of fluid obtained from the abscess grew K. pneumoniae, with an MIC for meropenem of 1 mg/L and for imipenem of 4 mg/L, was measured using Vitek2 (isolate 1, Table 1 ). Treatment with trimethoprim-sulfamethoxazole was initiated (tested susceptible).
In February 2007, the patient was readmitted because of neutropenic fever and empiric treatment with piperacillin/tazobactam was started. When blood cultures grew a K. pneumoniae (isolate 2) that was resistant to piperacillin/ tazobactam, therapy was switched to ceftriaxone. Shortly afterwards, she was readmitted because of a relapse of her pre-hepatic abscess. Drainage showed an ESBL-producing, but carbapenem-susceptible, E. coli (isolate 3, Table 1 ). Following meropenem treatment, the patient recovered and the abscess resolved. Later that month, rectal swabs revealed an ESBL-positive E. coli with an Etest MIC for meropenem of 8 mg/L and for imipenem of 8 mg/L (isolate 4, Table 1 ). The patient, ultimately, died in August 2007 due to respiratory failure, secondary to rituximab lung injury.
In 2013, a study was performed in the microbiology laboratory to validate a commercial microarray (Check-MDR CT103, Check-Points, Wageningen, The Netherlands) for the detection of ESBL and carbapenemase genes. Isolate 3, ESBL positive, was included in the historical collection that was used for this validation. The microarray revealed the presence of an OXA-48-like carbapenemase gene [1] . Isolate 2 and 4, retrieved from the freezer, were also tested positive for OXA-48-like carbapenemase gene in the microarray. Whole-genome sequencing was performed for both the E. coli and K. pneumoniae isolates using the Nextera XT v2kit (Illumina, San Diego, CA, USA) and run on a Miseq (Illumina, San Diego, CA,USA) as described by Zhou et al. [2] .
To identify the OXA-48 plasmid from the E. coli Sequence Type (ST) 866 and the K. pneumoniae ST648 
strain (STs were determined by whole-genome sequencing), the fragments encoding OXA-48 and transposase were selected from both strains and were blasted in the GenBank. (http://blast.ncbi.nlm.nih.gov/Blast.cgi). In total, 7 matches with plasmids were detected with 100 % identity and 76-100 % coverage. A local BLAST was then performed using the genomes of the two strains to blast against the seven plasmids, using the BLAST Ring Image Generator (BRIG) [3] . Similar results were found for the fragments from both strains. The best hit was an IncL/M plasmid (accession number: KC335143) from K. pneumoniae E71T, sharing 99 % identity with the plasmid of our strains, with a coverage of 100 % (Fig. 1) . In fact, another IncL/M plasmid pKPoxa-48N1 (accession number: KC575416.2) was also highly similar with our plasmid (99 % identity; coverage 98 %). The class D β-lactamase OXA-48 conferring decreased susceptibility to carbapenems was first identified in a K. pneumoniae isolate in Turkey [4] . Since then, multiple other OXA-48-producing isolates of various Enterobacteriaceae species have been reported. At first, these strains were mainly found in Turkey [5, 6] but recently also in other parts of the world, i.e., northern Africa and Europe [7] [8] [9] . The first publication of an OXA-48-producing Enterobacteriaceae, in The Netherlands, until now was dated in 2010 [10] . This patient was transferred from a hospital in India. Our findings show that OXA-48-producing Enterobacteriaceae were present in the Netherlands several years earlier. Although the time between the patient's visit to Turkey and positive culture is quite long, we assume that this resistance trait originates from Turkey. Indeed, long-term carriage is a well-known phenomenon for resistant Gramnegative bacteria and OXA-48 is assumed to originate from Northern Africa and Turkey [5] [6] [7] . Unfortunately, isolate 1, the first isolate obtained from the patient, had not been stored. Therefore, we were not able to determine if this isolate also contained the OXA-48 gene.
ESBL-negative OXA-48 isolates are difficult to detect as the MICs for ceftazidime and/or ceftriaxone are usually in the susceptible range. After the acquisition of an additional CTX-M-15-bearing plasmid, the MICs (and zone differences in the combined disk ESBL test) increased considerable, as shown in Table 1 . OXA-48 confers resistance to carbapenems but spares oxyiminocephalosporin.
We have to realise that the case, described in this case report, occurred at a time when only clinical breakpoints Fig. 1 Plasmid comparison generated by BRIG, with plasmid E71T used as a reference were available. No screening breakpoints were used to identify strains suspected for carbapenemase production [11, 12] . This isolate would have been recognized as a possible carbapenemase producer using the current Dutch National guideline for the detection of resistant microorganisms; the MIC screening breakpoint for meropenem has been set at >0.25 mg/L for all Enterobacteriaceae, and the breakpoint for imipenem at >1 mg/L for E. coli, Klebsiella spp., Salmonella spp., Enterobacter spp., and Citrobacter spp. [13] .
The presence of bla OXA-48 , in K. pneumoniae (first), as well as in E. coli (months later), suggests horizontal transfer of an OXA-48-encoding plasmid within one patient. Successful horizontal transfer of OXA-48-encoding plasmids within patients had been reported previously in the UK and France [14, 15] . In addition, Berger et al. showed that the mobilization of the OXA-48 gene is not restricted to the transfer of a single plasmid, but may also be involved in multiple rearrangements from different plasmids originating from different Enterobacteriaceae species [16] .
In summary, this case report shows that OXA-48 carbapenemase can easily be missed without adequate detection procedures. Therefore, this resistance trait was not recognized at the time that the patient was hospitalized. Our observation stresses the importance of uniform and adequate detection methods for early recognition and optimal management of patients with resistant pathogens.
